Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shah

Showing results (201-210 of 296) with videos related to

Pageof 30
Sort By:
CA: a Cancer Journal for Clinicians|December 10, 2025
Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumorsMohamed E Abdelsalam, Kamran Ahrar, Rahul A Sheth, et al.
Digestive Diseases and Sciences|November 25, 2020
High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt CreationMarie-Louise Kloster, Albert Ren, Ketan Y Shah, et al.
International Journal of Cancer|March 19, 2021
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experienceOmar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, et al.
Oncogene|July 17, 2012
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancerT Ezponda, R Popovic, M Y Shah, et al.
Gut|March 21, 2006
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseM Adachi, R Kurotani, K Morimura, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 24, 2021
Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical OutcomesKetan Y Shah, Albert Ren, Russell O Simpson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2019
Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric studyAditi Bhatt, Yutaka Yonemura, Nazim Benzerdjeb, et al.
Biomedicines|June 26, 2025
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell CarcinomaMohamed E Abdelsalam, Ahmed Awad, Roland L Bassett, et al.
Radiology. Imaging Cancer|September 19, 2025
Predicting Clinical Success of CT-based Functional Drained Liver Volume Assessment in Malignant Biliary ObstructionEthan Y Lin, Bruno C Odisio, Koustav Pal, et al.
The Oncologist|April 1, 2021
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor TherapiesAndrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, et al.
Pageof 30

Showing results (201-210 of 296) with videos related to

Sort By:
Pageof 30
CA: a Cancer Journal for Clinicians|December 10, 2025
Interventional oncology: A primer for clinicians on the role of ablation and embolization for solid tumorsMohamed E Abdelsalam, Kamran Ahrar, Rahul A Sheth, et al.
Digestive Diseases and Sciences|November 25, 2020
High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt CreationMarie-Louise Kloster, Albert Ren, Ketan Y Shah, et al.
International Journal of Cancer|March 19, 2021
Outcomes of patients with intermediate-risk or poor-risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experienceOmar Alhalabi, Elshad Hasanov, Nathaniel R Wilson, et al.
Oncogene|July 17, 2012
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancerT Ezponda, R Popovic, M Y Shah, et al.
Gut|March 21, 2006
Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseM Adachi, R Kurotani, K Morimura, et al.
Journal of Vascular and Interventional Radiology : JVIR|January 24, 2021
Combined Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Obliteration versus Transjugular Intrahepatic Portosystemic Shunt Alone for the Management of Gastric Varices: Comparative Single-Center Clinical OutcomesKetan Y Shah, Albert Ren, Russell O Simpson, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 25, 2019
Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential-a prospective multi-centric studyAditi Bhatt, Yutaka Yonemura, Nazim Benzerdjeb, et al.
Biomedicines|June 26, 2025
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell CarcinomaMohamed E Abdelsalam, Ahmed Awad, Roland L Bassett, et al.
Radiology. Imaging Cancer|September 19, 2025
Predicting Clinical Success of CT-based Functional Drained Liver Volume Assessment in Malignant Biliary ObstructionEthan Y Lin, Bruno C Odisio, Koustav Pal, et al.
The Oncologist|April 1, 2021
Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor TherapiesAndrew J Wiele, Tharakeswara K Bathala, Andrew W Hahn, et al.
Pageof 30